{"id":274602,"date":"2026-09-28T12:24:38","date_gmt":"2026-09-28T06:54:38","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=274602"},"modified":"2026-09-28T12:24:38","modified_gmt":"2026-09-28T06:54:38","slug":"why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-28","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-28\/","title":{"rendered":"Glaxosmithkline Pharmaceuticals Ltd. (GLAXO): Glaxosmithkline Pharmaceuticals Share Price rises 4.17% today"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/glaxo\/glaxosmithkline-pharmaceuticals-ltd-share-price-today\">Glaxosmithkline Pharmaceuticals Ltd. (GLAXO)<\/a> share price rose to Rs 2,934.35 today, up 4.17% from the previous close. Market cap was Rs 47,719.14 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong> 28 September 2026 at 12:22:35 PM IST<\/p>\n<p style=\"margin-top:0!important;\">Glaxosmithkline Pharmaceuticals Share Price moved higher today, with GLAXO ending at Rs 2,934.35 after a 4.17% rise from the previous close of Rs 2,816.85. The move added Rs 117.50 to the stock and came within a session that opened at Rs 2,812, touched a high of Rs 2,986.65 and a low of Rs 2,788.80. Those numbers show a firm upward day, but the supplied data does not identify any company-specific catalyst. For readers following Glaxosmithkline Pharmaceuticals Share Price Today, the important point is the verified market action: a higher close, a wide intraday range and a meaningful move in a large healthcare name. The company\u2019s market capitalisation stood at Rs 47,719.14 crore, which helps place the day\u2019s gain in a clear market-cap context.<\/p>\n<p>That context matters because Glaxosmithkline Pharmaceuticals Share Price did not just rise in isolation; it did so while trading near the upper end of the day\u2019s range. The close was below the session high but comfortably above the opening level and the previous close. In practical terms, that means buyers were able to keep control through much of the session even though the price also visited a lower point during the day. Turnover stood at Rs 2.73 crore, which records the day\u2019s market activity without implying any specific trading pattern beyond the reported figure. The verified facts therefore support a straightforward event summary: GLAXO had a positive day, closed higher, and did so with a notable intraday swing.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-28\/#Glaxosmithkline_Pharmaceuticals_Share_Price_Today_Price_Action_Analysis\" title=\"Glaxosmithkline Pharmaceuticals Share Price Today: Price Action Analysis\">Glaxosmithkline Pharmaceuticals Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-28\/#Glaxosmithkline_Pharmaceuticals_Ltd_GLAXO_Fundamental_Analysis\" title=\"Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) Fundamental Analysis\">Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-28\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-28\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-28\/#Why_Investors_Are_Watching_Glaxosmithkline_Pharmaceuticals\" title=\"Why Investors Are Watching Glaxosmithkline Pharmaceuticals\">Why Investors Are Watching Glaxosmithkline Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-28\/#About_Glaxosmithkline_Pharmaceuticals\" title=\"About Glaxosmithkline Pharmaceuticals\">About Glaxosmithkline Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-28\/#Track_Glaxosmithkline_Pharmaceuticals_Share_Price_on_Univest\" title=\"Track Glaxosmithkline Pharmaceuticals Share Price on Univest\">Track Glaxosmithkline Pharmaceuticals Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-28\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-28\/#Why_did_Glaxosmithkline_Pharmaceuticals_Share_Price_rise_today\" title=\"Why did Glaxosmithkline Pharmaceuticals Share Price rise today?\">Why did Glaxosmithkline Pharmaceuticals Share Price rise today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-28\/#What_is_Glaxosmithkline_Pharmaceuticals_Share_Price_today\" title=\"What is Glaxosmithkline Pharmaceuticals Share Price today?\">What is Glaxosmithkline Pharmaceuticals Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-28\/#What_is_the_market_capitalisation_of_Glaxosmithkline_Pharmaceuticals\" title=\"What is the market capitalisation of Glaxosmithkline Pharmaceuticals?\">What is the market capitalisation of Glaxosmithkline Pharmaceuticals?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-28\/#How_expensive_is_Glaxosmithkline_Pharmaceuticals_based_on_valuation\" title=\"How expensive is Glaxosmithkline Pharmaceuticals based on valuation?\">How expensive is Glaxosmithkline Pharmaceuticals based on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-28\/#What_do_EPS_and_book_value_show_for_Glaxosmithkline_Pharmaceuticals_Share_Price\" title=\"What do EPS and book value show for Glaxosmithkline Pharmaceuticals Share Price?\">What do EPS and book value show for Glaxosmithkline Pharmaceuticals Share Price?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Glaxosmithkline_Pharmaceuticals_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Glaxosmithkline Pharmaceuticals Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,934.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,816.85<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 117.5 (+4.17%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,812<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,986.65<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,788.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2.73 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 47,719.14 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/table>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) rose to Rs 2,934.35 from the previous close of Rs 2,816.85, a move of Rs 117.5 or 4.17%. The stock opened at Rs 2,812, reached a high of Rs 2,986.65, recorded a low of Rs 2,788.8.<\/p>\n<p>The strongest part of this update is the price action itself. Glaxosmithkline Pharmaceuticals Share Price moved from the previous close of Rs 2,816.85 to Rs 2,934.35, and that Rs 117.50 advance translated into a 4.17% rise. The stock opened only slightly below the previous close at Rs 2,812, which means the session started without a sharp gap and then built upward through the day. A high of Rs 2,986.65 shows that the stock briefly traded above the closing level by a meaningful margin, while the low of Rs 2,788.80 shows that the day was not one-way. This combination usually signals active price discovery, not a straight-line move.<\/p>\n<p>For Glaxosmithkline Pharmaceuticals Share Price, the relationship between open, low, high and close is more informative than the percentage change alone. The stock spent the session inside a range of nearly Rs 200, yet finished close to the upper half of that band. That tells readers that the rise was achieved despite some intraday back-and-forth. A higher close after a broad range is often the most useful way to read a session like this, because it separates the final outcome from the day\u2019s temporary swings. In this case, the final price action is clearly positive and the close sits well above the previous session\u2019s reference point.<\/p>\n<p>The turnover of Rs 2.73 crore adds another layer of context. It confirms that the move occurred in an active trading session, but the figure should be read only as market activity data. It does not tell us why the stock moved, and the available information does not support a deeper cause. Still, when combined with the day\u2019s range and closing level, it helps explain why GLAXO share price news attracted attention today. The move was visible, measurable and large enough to matter for a stock of this size.<\/p>\n<p>Another useful takeaway is that the rise was not mirrored by a dramatic opening spike. Since the stock opened at Rs 2,812, the day began close to the prior close and then improved over the course of trading. That pattern can be helpful for readers looking at Glaxosmithkline Pharmaceuticals Share Price as an event-based stock update rather than as a charting exercise. The session facts show a constructive day with a higher settlement, and that is the central market story supplied by the data.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Glaxosmithkline_Pharmaceuticals_Ltd_GLAXO_Fundamental_Analysis\"><\/span><strong>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 47,719.14 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">44.67x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.93x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.76%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">66.79%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 63.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 148.77<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.02%<\/td>\n<\/tr>\n<\/table>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) fundamental metrics show P\/E 44.67x, P\/B 18.93x, ROE 48.76%, ROCE 66.79%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Glaxosmithkline Pharmaceuticals Ltd. has a market capitalisation of Rs 47719.14 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 44.67x, P\/B at 18.93x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 48.76% and ROCE of 66.79%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 63.05, book value per share of Rs 148.77, dividend yield of 2.02%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 32.87x, median ROE of 11.48%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">44.67x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.87x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.63x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.46x to 735.85x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.93x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.85x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.76%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.48%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">66.79%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.17%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 47,719.14 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 732.57 crore<\/td>\n<\/tr>\n<\/table>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a P\/E ratio of 44.67x, which is above the benchmark median of 32.87x, a difference of +35.9%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a ROE of 48.76%, which is above the benchmark median of 11.48%, a difference of +324.74%. Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a ROCE of 66.79%, which is above the benchmark median of 13.17%, a difference of +407.14%.<\/p>\n<p>Track stocks leading today through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,44,716.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">36.77<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.14<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Divi&#39;s Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,55,115.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">87.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.44<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,89,613.38<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">86.94<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,19,899.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.57<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,12,875.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.49<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a P\/E ratio of 44.67x compared with the displayed peer median of 36.77x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 48.76% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 66.79% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a market capitalisation of Rs 47,719.14 crore. Among the 5 peers shown, 5 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Glaxosmithkline_Pharmaceuticals\"><\/span><strong>Why Investors Are Watching Glaxosmithkline Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Glaxosmithkline Pharmaceuticals Share Price rose 4.17% today to Rs 2,934.35 after closing above the previous close of Rs 2,816.85.<\/li>\n<li>The stock moved between Rs 2,788.80 and Rs 2,986.65 during the session, showing an active intraday range.<\/li>\n<li>Market capitalisation stood at Rs 47,719.14 crore, giving the move a sizeable market-cap backdrop.<\/li>\n<li>P\/E of 44.67 and P\/B of 18.93 place the stock above the industry median on valuation measures.<\/li>\n<li>ROE of 48.76%, ROCE of 66.79%, EPS of Rs 63.05 and book value of Rs 148.77 are key financial metrics in the stock update.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Glaxosmithkline_Pharmaceuticals\"><\/span><strong>About Glaxosmithkline Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Glaxosmithkline Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. The company name and industry classification place it within a regulated pharmaceutical business environment, where valuation and return ratios often matter to market participants. In today\u2019s stock news, the company\u2019s market capitalisation of Rs 47,719.14 crore shows a meaningful listed presence within the same industry. The supplied data does not include a segment-wise revenue mix or product breakdown, so the article stays with verified company-level facts. As a result, the most useful company news framing is simple: this is a pharmaceutical business whose share price, financial ratios and peer positioning are now in focus after the same-day rise. Univest is tracking Glaxosmithkline Pharmaceuticals Share Price Today for readers who want the market update in one place.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Glaxosmithkline_Pharmaceuticals_Share_Price_on_Univest\"><\/span><strong>Track Glaxosmithkline Pharmaceuticals Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/glaxo\/glaxosmithkline-pharmaceuticals-ltd-share-price-today\">Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top-gainers lists and related market analysis.<\/p>\n<p>Use the Glaxosmithkline Pharmaceuticals live share-price page, the Univest top gainers screener and Univest market blogs to review live stock data, top-gainers lists and related market analysis. These pages help readers follow Glaxosmithkline Pharmaceuticals Share Price alongside other active names without relying on a single session alone.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE and BSE websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Glaxosmithkline_Pharmaceuticals_Share_Price_rise_today\"><\/span><strong>Why did Glaxosmithkline Pharmaceuticals Share Price rise today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The data confirms a 4.17% same-day rise in Glaxosmithkline Pharmaceuticals Share Price, but it does not establish a company-specific catalyst. The verified facts are the price move, session range, turnover and market capitalisation.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Glaxosmithkline_Pharmaceuticals_Share_Price_today\"><\/span><strong>What is Glaxosmithkline Pharmaceuticals Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Glaxosmithkline Pharmaceuticals Share Price today is Rs 2,934.35. It gained Rs 117.50 over the previous close of Rs 2,816.85, and the session high was Rs 2,986.65 while the low was Rs 2,788.80.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Glaxosmithkline_Pharmaceuticals\"><\/span><strong>What is the market capitalisation of Glaxosmithkline Pharmaceuticals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The market capitalisation of Glaxosmithkline Pharmaceuticals stood at Rs 47,719.14 crore. That places the company well above the industry median and average in the supplied same-industry benchmark set. The company operates in the Healthcare sector.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_expensive_is_Glaxosmithkline_Pharmaceuticals_based_on_valuation\"><\/span><strong>How expensive is Glaxosmithkline Pharmaceuticals based on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock trades at a P\/E of 44.67 and a P\/B of 18.93. Those levels are above the industry median in the supplied dataset, while ROE and ROCE are also notably strong, which gives the valuation more context.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_EPS_and_book_value_show_for_Glaxosmithkline_Pharmaceuticals_Share_Price\"><\/span><strong>What do EPS and book value show for Glaxosmithkline Pharmaceuticals Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> EPS is Rs 63.05 and book value is Rs 148.77. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share. Both help frame valuation and the stock\u2019s financial profile.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Glaxosmithkline Pharmaceuticals Ltd. Share Price rises to Rs 2,934.35. marking a 4.17% rise today. Market cap stands at Rs 47,719.14 crore.<\/p>\n","protected":false},"author":29,"featured_media":274599,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-274602","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["274599"],"rank_math_title":["Glaxosmithkline Pharmaceuticals Share Price rises 4.17%"],"rank_math_description":["Glaxosmithkline Pharmaceuticals Share Price rose 4.17% today to Rs 2,934.35. Read the price action, fundamentals, sector and peer analysis."],"rank_math_focus_keyword":["Glaxosmithkline Pharmaceuticals Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/glaxosmithkline-pharmaceuticals-ltd-glaxo-glaxosmithkline-pharmaceuticals-share.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/274602","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=274602"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/274602\/revisions"}],"predecessor-version":[{"id":274604,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/274602\/revisions\/274604"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/274599"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=274602"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=274602"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=274602"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}